Multidisciplinary Respiratory Medicine最新文献

{"title":"Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life - a meta-analysis of randomized, placebo-controlled trials.","authors":"Peter Kardos,&nbsp;Walter Lehmacher,&nbsp;Andrea Zimmermann,&nbsp;Juliette Brandes-Schramm,&nbsp;Petra Funk,&nbsp;Heinrich Matthys,&nbsp;Wolfgang Kamin","doi":"10.4081/mrm.2022.868","DOIUrl":"https://doi.org/10.4081/mrm.2022.868","url":null,"abstract":"<p><strong>Background: </strong>Cough is a leading symptom of viral acute respiratory infections such as acute bronchitis (AB) and the common cold (CC), which can be debilitating and may persist for several weeks. We investigated whether treatment with <i>Pelargonium</i> extract EPs 7630 may reduce cough and improve disease-related quality of life (QoL).</p><p><strong>Methods: </strong>We performed a meta-analysis of randomized, placebo-controlled trials investigating the efficacy of EPs 7630 in AB or CC. Efficacy analyses included change from baseline in a cough intensity score, remission of cough, and disease-associated impairments of QoL.</p><p><strong>Results: </strong>Data of 2,195 participants from 11 trials (3 in children/adolescents with AB, 3 in adults with AB, 5 in adults with CC) were eligible. In children/adolescents with AB, 79.6% of participants treated with EPs 7630 and 41% treated with placebo showed a reduction in the intensity of cough by at least 50% of baseline values at day 7 [meta-analysis rate/risk ratio (RR), EPs 7630 / placebo: 1.86 (95% CI: 1.34; 2.95)], and 18.0% <i>vs</i> 5.5% presented with complete remission of cough [RR: 2.91 (95% CI: 1.26; 6.72)]. In adults with AB, 88.7% of participants in the EPs 7630 group and 47.6% in the placebo group showed a ≥50% response for cough intensity [RR: 2.13 (95% CI: 1.37; 3.31)], while 26.0% <i>vs</i> 6.3% did not cough any more at day 7 [RR: 5.00 [95% CI: 3.10; 8.07)]. Cough scale results were supported by significant improvements over placebo in the pursuit of normal daily activities and other QoL measures. In CC, 56.8% of participants treated with EPs 7630 and 38.8% treated with placebo showed a ≥50% cough intensity reduction [RR: 1.40 (95% CI: 1.19; 1.65)] at day 5, while 26.1% <i>versus</i> 18.4% showed complete remission of cough for EPs 7630 and placebo, respectively [RR: 1.40 (95% CI: 1.06; 1.84)]. CCassociated pain/discomfort and impairment of usual activities were no longer present in 41.5% and 48.8% of participants treated with EPs 7630 compared to less than 40% of patients in the placebo group.</p><p><strong>Conclusions: </strong>The results show that EPs 7630 reduces the burden and leads to earlier remission of cough. Advantages for EPs 7630 were also reflected in self-rated measures of disease-associated QoL. Of note, patients treated with the herbal product felt able to resume their usual daily activities sooner.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" ","pages":"868"},"PeriodicalIF":2.3,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/b5/mrm-17-1-868.PMC9425964.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40344002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The influence of policies limiting author self-citations on journals impact factor and self-citation rate in respiratory system.","authors":"Filippo Sanfilippo,&nbsp;Claudia Crimi,&nbsp;Alberto Morgana,&nbsp;Luigi La Via,&nbsp;Marinella Astuto","doi":"10.4081/mrm.2022.871","DOIUrl":"https://doi.org/10.4081/mrm.2022.871","url":null,"abstract":"<p><p>To assess the presence of journal policies discouraging inappropriate author's self-citation (A-SC) in \"Respiratory System\" journals, we evaluated submission guidelines of \"Respiratory System\" journals included in Journal-Citation Reports 2020 (Clarivate Analytics^®) for the presence of policies on A-SC and its impact on journals' self-citation (J-SC) rate and impact factor (IF). We found that 14.3% of journals (n=8/56) reported policies on inappropriate A-SC. The median IF was not different in \"Respiratory System\" journals with (3.6; IQR:2.3) <i>vs</i> without A-SC policies (3.1; IQR:3.0; p=0.41). The J-SC rate was not influenced by the presence of A-SC policies (p=0.83). Fully open-access (n=14) and traditional (n=42) journals had no differences in IF (3.3; IQR:1.5 <i>vs</i> 3.1; IQR:3.4, respectively; p=0.77) and J-SC rate (4.5%; IQR:5.6 <i>vs</i> 6.2%; IQR:8.4, respectively; p=0.38). The majority of \"Respiratory System\" journals do not have policies discouraging A-SC. The presence of such policies is not associated with changes in IF or J-SC rates.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" ","pages":"871"},"PeriodicalIF":2.3,"publicationDate":"2022-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/2b/mrm-17-1-871.PMC9425953.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40344003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A putative link between pertussis and new onset of gastroesophageal reflux an observational study.","authors":"Leticia Burton,&nbsp;Daminda P Weerasinghe,&nbsp;David Joffe,&nbsp;Jennifer Saunders,&nbsp;Gregory L Falk,&nbsp;Hans Van der Wall","doi":"10.4081/mrm.2022.832","DOIUrl":"https://doi.org/10.4081/mrm.2022.832","url":null,"abstract":"<p><strong>Background: </strong>Pertussis is an infectious disease of the respiratory tract with a changing epidemiology. An increasing incidence has been found in the adult population with recurrent infections possibly related to changes in the current vaccine. Is there an association between pertussis infection, refractory cough and atypical gastro-oesophageal reflux (GORD)? Does this magnify and compound respiratory complications?</p><p><strong>Methods: </strong>Observational study which compares post-pertussis (n=103) with non-pertussis patients (n=105) with established GORD. Patients were assessed for laryngopharyngeal reflux and aspiration of refluxate by a novel scintigraphic study.</p><p><strong>Results: </strong>Both groups showed severe GORD in association with high rates of laryngopharyngeal reflux (LPR) and pulmonary aspiration and lung disease. High rates of hiatus hernia and clinical diagnosis of \"atypical\" asthma showed correlations with pulmonary aspiration.</p><p><strong>Conclusions: </strong>A high level of new onset LPR and lung aspiration has been shown in patients with chronic cough after recent pertussis infection by a novel scintigraphic technique with fused hybrid x-ray computed tomography (SPECT/CT).</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" ","pages":"832"},"PeriodicalIF":2.3,"publicationDate":"2022-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/94/mrm-17-1-832.PMC9295390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40528864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The practical role of the respiratory therapist in the standard apnea test procedure for declaration of death via neurologic criteria in adults.","authors":"Adrian A Jarquin-Valdivia,&nbsp;Earl B Glasgow,&nbsp;Todd J Meyer","doi":"10.4081/mrm.2022.843","DOIUrl":"https://doi.org/10.4081/mrm.2022.843","url":null,"abstract":"<p><strong>Introduction: </strong>Respiratory therapists (RTs) in the intensive care unit can at times find themselves involved in and assisting during the performance of the apnea test (ApT). The ApT is a clinically complex procedure and is the last part of the clinical declaration of death by neurologic criteria (DNC) protocol and requires close collaboration between the physicians and the RTs. As such, the ApT should be performed with the upmost attention to detail.</p><p><strong>Context and aims: </strong>The RTs need to be versed on the intricacies of the ApT. Except in very large medical centers, the ApT is not a procedure performed with high enough frequency as to maintain high level of proficiency. For a successful ApT, structured knowledge and preparation are paramount. This publication attempts to fill that gap, for adult hospitalized patients not on ECMO (extracorporeal membrane oxygenation). To generate this report, we make use of the published guidelines, and our personal experience on performing ApTs in large medical centers.</p><p><strong>Conclusion: </strong>We provide a structure by means of a checklist, from the RTs' perspective, to guide and help them lead on the efficient performance of the ApT.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" ","pages":"843"},"PeriodicalIF":2.3,"publicationDate":"2022-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/11/mrm-17-1-843.PMC9261955.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diaphragmatic excursion by ultrasound: reference values for the normal population; a cross-sectional study in Egypt.","authors":"Ahmed E Kabil,&nbsp;Eman Sobh,&nbsp;Mahmoud Elsaeed,&nbsp;Houssam Eldin Hassanin,&nbsp;Ibrahim H Yousef,&nbsp;Heba H Eltrawy,&nbsp;Ahmed M Ewis,&nbsp;Ahmed Aboseif,&nbsp;AbdAllah M Albalsha,&nbsp;Sawsan Elsawy,&nbsp;Abdul Rahman H Ali","doi":"10.4081/mrm.2022.842","DOIUrl":"https://doi.org/10.4081/mrm.2022.842","url":null,"abstract":"<p><strong>Background: </strong>Measurement of diaphragmatic motion by ultrasound is being utilized in different aspects of clinical practice. Defining reference values of the diaphragmatic excursion is important to identify those with diaphragmatic motion abnormalities. This study aimed to define the normal range of diaphragmatic motion (reference values) by Mmode ultrasound for the normal population.</p><p><strong>Methods: </strong>Healthy volunteers were included in this study. Those with comorbidities, skeletal deformity, acute or chronic respiratory illness were excluded. Diaphragmatic ultrasound in the supine position was performed using a lowfrequency probe. The B-mode was applied for diaphragmatic identification, and the M-mode was employed for the recording of the amplitude of diaphragm contraction during quiet breathing, deep breathing and sniffing.</p><p><strong>Results: </strong>The study included 757 healthy subjects [478 men (63.14%) and 279 women (36.86%)] with normal spirometry and negative history of previous or current respiratory illness. Their mean age and BMI were 45.17 ±14.84 years and 29.36±19.68 (kg/m²). The mean right hemidiaphragmatic excursion was 2.32±0.54, 5.54±1.26 and 2.90±0.63 for quiet breathing, deep breathing and sniffing, respectively, while the left hemidiaphragmatic excursion was 2.35±0.54, 5.30±1.21 and 2.97±0.56 cm for quiet breathing, deep breathing and sniffing, respectively. There was a statistically significant difference between right and left diaphragmatic excursion among all studied subjects. The ratio of right to left diaphragmatic excursion during quiet breathing was (1.009±0.19); maximum 181% and minimum 28%. Only 19 cases showed a right to left ratio of less than 50% (5 men and 14 women). The diaphragmatic excursion was higher in males than females. There was a significant difference in diaphragmatic excursion among age groups. Age, sex and BMI significantly affected the diaphragmatic motion.</p><p><strong>Conclusions: </strong>Diaphragmatic excursion values presented in this study can be used as reference values to detect diaphragmatic dysfunction in clinical practice. Diaphragmatic motion is affected by several factors including age, sex and body mass index.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":" ","pages":"842"},"PeriodicalIF":2.3,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/6a/mrm-17-1-842.PMC9220962.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40400383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab.","authors":"Francesco Menzella,&nbsp;Carla Galeone,&nbsp;Giulia Ghidoni,&nbsp;Patrizia Ruggiero,&nbsp;Silvia Capobelli,&nbsp;Anna Simonazzi,&nbsp;Chiara Catellani,&nbsp;Chiara Scelfo,&nbsp;Francesco Livrieri,&nbsp;Nicola Facciolongo","doi":"10.4081/mrm.2021.779","DOIUrl":"https://doi.org/10.4081/mrm.2021.779","url":null,"abstract":"<p><strong>Introduction: </strong>Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by necrotizing eosinophilic granulomatous inflammation that frequently involves the respiratory tract (90% of cases). Asthma in EGPA is systematically severe and often refractory to common treatment, it is corticosteroid resistant and can often anticipate the onset of systemic vasculitis by many years. A release of cytokines necessary for the activation, maturation and survival of eosinophils, such as IL-4, IL-5 and IL-13 occurs in the activated Th-2 phenotype. In particular, IL-5 level is high in active EGPA and its inhibition has become a key therapeutic target. Oral glucocorticoids (OCS) are effective treatment options but unfortunately, frequent relapses occur in many patients and they lead to frequent side effects. As for now, there are currently no official recommendations on doses and treatment schedules in the management of EGPA.</p><p><strong>Case presentation: </strong>In this article, we describe the case of a man with EGPA, severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), with poor asthma and CRSwNP control despite OCS and mepolizumab treatment. Respiratory and vasculitis symptoms improved markedly after therapeutic switch to benralizumab. During the treatment, in addition to clinical effects, we witnessed a depletion of blood eosinophils, as well as an improvement in both pulmonary function tests, CT scan and skin lesions present initially.</p><p><strong>Conclusions: </strong>While there are many studies confirming the efficacy of benralizumab in EGPA, the most interesting aspect of our report is that efficacy was confirmed in a patient previously unresponsive to mepolizumab, known to be effective in EGPA.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"16 1","pages":"779"},"PeriodicalIF":2.3,"publicationDate":"2021-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6f/77/mrm-16-1-779.PMC8239622.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39150697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.","authors":"Asmaa M Zahran,&nbsp;Zeinab Albadry M Zahran,&nbsp;Yasmeen H Mady,&nbsp;Essam Eldeen M O Mahran,&nbsp;Alaa Rashad,&nbsp;Ahmed Makboul,&nbsp;Khalid A Nasif,&nbsp;Aida A Abdelmaksoud,&nbsp;Omnia El-Badawy","doi":"10.4081/mrm.2021.758","DOIUrl":"https://doi.org/10.4081/mrm.2021.758","url":null,"abstract":"<p><strong>Background: </strong>Viral infections cause alteration in the total number of lymphocytes and their subset distribution. We aimed to study peripheral blood lymphocyte subsets in COVID-19 patients and to correlate these subsets with clinical and laboratory data, which may help in clarifying the pathogenesis to develop novel diagnostic and prognostic biomarkers for COVID-19.</p><p><strong>Methods: </strong>Twenty-six reverse-transcription polymerase chain reaction (RT-PCR) confirmed COVID-19 patients were subjected to medical history-taking and a thorough clinical examination. Laboratory tests included complete blood count, D dimer, ferritin, and C-reactive protein (CRP). Chest CT was used to diagnose COVID-19 pneumonia. Lymphocyte subsets were compared with those in 20 healthy controls using flow cytometry.</p><p><strong>Results: </strong>Leucopenia, relative neutrophilia, lymphopenia, eosinopenia together with marked elevation in neutrophil/lymphocyte ratio were observed in our COVID-19 patients. A marked reduction was observed in T cells, including both CD4 and CD8 cells, natural killer (NK), and natural killer T cells (NKT). Double-positive T (DPT) cells, double-negative T (DNT) cells, and B cells were elevated in the patients relative to the other lymphocyte subsets.</p><p><strong>Conclusion: </strong>Immune-inflammatory parameters are of utmost importance in understanding the pathogenesis and in the provisional diagnosis of COVID-19. Yet, adequate care must be taken during their interpretation because of the vast discrepancies observed between studies even in the same locality. Further studies are needed to clarify the role of B cells, DPT, and DNT cells in the pathogenesis and control of COVID-19.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"16 2","pages":"758"},"PeriodicalIF":2.3,"publicationDate":"2021-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/60/mrm-16-1-758.PMC8215531.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39157757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Worsening of gas exchange parameters at high FiO₂ in COVID-19: misleading or informative?","authors":"Federico Raimondi,&nbsp;Luca Novelli,&nbsp;Gianmariano Marchesi,&nbsp;Fabrizio Fabretti,&nbsp;Lorenzo Grazioli,&nbsp;Ivano Riva,&nbsp;Chiara Allegri,&nbsp;Roberta Biza,&nbsp;Chiara Galimberti,&nbsp;Ferdinando Luca Lorini,&nbsp;Fabiano Di Marco","doi":"10.4081/mrm.2021.759","DOIUrl":"https://doi.org/10.4081/mrm.2021.759","url":null,"abstract":"<p><strong>Background: </strong>In COVID-19, higher than expected level of intrapulmonary shunt has been described, in association with a discrepancy between the initial relatively preserved lung mechanics and the hypoxia severity. This study aim was to measure the shunt fraction and variations of PaO₂/FiO₂ ratio and oxygen alveolar-arterial gradient (A-a O₂) at different FiO₂.</p><p><strong>Methods: </strong>Shunt was measured by a non-invasive system during spontaneous breathing in 12 patients hospitalized at COVID-19 Semi-Intensive Care Unit of Papa Giovanni XXIII Hospital, Bergamo, Italy, between October 22 and November 23, 2020.</p><p><strong>Results: </strong>Nine patients were men, mean age (±SD) 62±15 years, mean BMI 27.5±4.8 Kg/m². Systemic hypertension, diabetes type 2 and previous myocardial infarction were referred in 33%, 17%, and 7%, respectively. Mean PaO₂/FiO₂ ratio was 234±66 and 11 patients presented a bilateral chest X-ray involvement. Mean shunt was 21±6%. Mainly in patients with a more severe respiratory failure, we found a progressive decrease of PaO₂/FiO₂ ratio with higher FiO₂. Considering (A-a O₂), we found a uniform tendency to increase with FiO₂ increasing. Even in this case, the more severe were the patients, the higher was the slope, suggesting FiO₂ insensitiveness due to a shunt effect, as strengthened by our measurements.</p><p><strong>Conclusion: </strong>Relying on a single evaluation of PaO₂/FiO₂ ratio, especially at high FiO₂, could be misleading in COVID-19. We propose a two steps evaluation, the first at low SpO₂ value (<i>e.g</i>., 92-94%) and the second one at high FiO₂ (<i>i.e</i>., >0.7), allowing to characterize both the amendable (ventilation/perfusion mismatch), and the fixed (shunt) contribution quote of respiratory impairment, respectively.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"16 1","pages":"759"},"PeriodicalIF":2.3,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/76/mrm-16-1-759.PMC8168493.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39090596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study.","authors":"Irene Coloretti,&nbsp;Stefano Busani,&nbsp;Emanuela Biagioni,&nbsp;Sophie Venturelli,&nbsp;Elena Munari,&nbsp;Marco Sita,&nbsp;Lorenzo DallAra,&nbsp;Martina Tosi,&nbsp;Enrico Clini,&nbsp;Roberto Tonelli,&nbsp;Riccardo Fantini,&nbsp;Cristina Mussini,&nbsp;Marianna Meschiari,&nbsp;Giovanni Guaraldi,&nbsp;Andrea Cossarizza,&nbsp;Gaetano Alfano,&nbsp;Massimo Girardis","doi":"10.4081/mrm.2021.737","DOIUrl":"https://doi.org/10.4081/mrm.2021.737","url":null,"abstract":"<p><strong>Background: </strong>The use of cytokine-blocking agents has been proposed to modulate the inflammatory response in patients with COVID-19. Tocilizumab and anakinra were included in the local protocol as an optional treatment in critically ill patients with acute respiratory distress syndrome (ARDS) by SARS-CoV-2 infection. This cohort study evaluated the effects of therapy with cytokine blocking agents on in-hospital mortality in COVID-19 patients requiring mechanical ventilation and admitted to intensive care unit.</p><p><strong>Methods: </strong>The association between therapy with tocilizumab or anakinra and in-hospital mortality was assessed in consecutive adult COVID-19 patients admitted to our ICU with moderate to severe ARDS. The association was evaluated by comparing patients who received to those who did not receive tocilizumab or anakinra and by using different multivariable Cox models adjusted for variables related to poor outcome, for the propensity to be treated with tocilizumab or anakinra and after patient matching.</p><p><strong>Results: </strong>Sixty-six patients who received immunotherapy (49 tocilizumab, 17 anakinra) and 28 patients who did not receive immunotherapy were included. The in-hospital crude mortality was 30,3% in treated patients and 50% in nontreated (OR 0.77, 95% CI 0.56-1.05, p=0.069). The adjusted Cox model showed an association between therapy with immunotherapy and in-hospital mortality (HR 0.40, 95% CI 0.19-0.83, p=0.015). This protective effect was further confirmed in the analysis adjusted for propensity score, in the propensity-matched cohort and in the cohort of patients with invasive mechanical ventilation within 2 hours after ICU admission.</p><p><strong>Conclusions: </strong>Although important limitations, our study showed that cytokine-blocking agents seem to be safe and to improve survival in COVID-19 patients admitted to ICU with ARDS and the need for mechanical ventilation.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"16 1","pages":"737"},"PeriodicalIF":2.3,"publicationDate":"2021-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/30/mrm-16-1-737.PMC8139121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39022829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Utility of a modified distress thermometer in screening COVID-19 patients for psychological distress: a prospective Egyptian study.","authors":"Sherif A A Mohamed, Azza AbdelHafeez, Ehab Kamel, Alaa Rashad","doi":"10.4081/mrm.2021.750","DOIUrl":"10.4081/mrm.2021.750","url":null,"abstract":"<p><strong>Background: </strong>The National Comprehensive Cancer Network (NCCN) has adopted the distress thermometer (DT) as one of the best-known distress-screening instruments. We have adopted a modified version of the NCCN distress thermometer. We questioned if this modified DT (m-DT) could be utilized for measuring the prevalence of psychological distress among COVID-19 patients.</p><p><strong>Methods: </strong>The prospective study included 2 phases; modification of the original DT and its associated problem list (PL), and evaluation of this m-DT in measuring the prevalence of psychological distress among COVID-19 patients. Egyptian adult subjects with suspected or confirmed cases of COVID-19 at 2 University Hospitals were enrolled. Binary logistic regression tests were carried out to explore the association between the m-DT cut-off scores of 4 and the clinical variables.</p><p><strong>Results: </strong>One hundred sixty-nine (60.4%) patients experienced significant distress (m-DT cut off score ≥4). Logistic regression showed that occupation, presence of special habits, length of quarantine time, worry, cough, shortness of breath, and fever, were independent factors associated with significant distress in COVID-19 patients.</p><p><strong>Conclusion: </strong>With the modified distress thermometer (m-DT), 60% of Egyptian COVID-19 patients experienced significant distress. This distress was significantly related to age, marital status, occupation, presence or absence of special habits, and length of the quarantine time. With m-DT, the current study had identified worry, being a health-care worker, shortness of breath, fever, length of quarantine time, presence of special habits, and cough as independent factors associated with significant distress in COVID-19 patients. Further studies are warranted.</p>","PeriodicalId":49031,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"16 1","pages":"750"},"PeriodicalIF":2.3,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/ae/mrm-16-1-750.PMC8082533.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38928436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}